HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrence of acute anterior inflammation after intravitreal injection of bevacizumab in uveitis.

AuthorsAnnabelle A Okada, Hiroshi Keino, Takayo Watanabe, Wakako Taki, Ruriko Hayakawa
JournalJapanese journal of ophthalmology (Jpn J Ophthalmol) Vol. 53 Issue 2 Pg. 182-184 (Mar 2009) ISSN: 1613-2246 [Electronic] Japan
PMID19333706 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
Topics
  • Acute Disease
  • Angiogenesis Inhibitors (adverse effects)
  • Antibodies, Monoclonal (adverse effects)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Fluorescein Angiography
  • Glucocorticoids (therapeutic use)
  • Humans
  • Inflammation (chemically induced, drug therapy, physiopathology)
  • Injections
  • Macular Edema (drug therapy)
  • Middle Aged
  • Recurrence
  • Retinal Neovascularization (drug therapy)
  • Uveitis, Anterior (chemically induced, drug therapy, physiopathology)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Visual Acuity
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: